CDKN2A Gene (Protein Coding)

Cyclin Dependent Kinase Inhibitor 2A

GC09M021967
GIFtS:
51
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the g... See more...

Aliases for CDKN2A Gene

Aliases for CDKN2A Gene

  • Cyclin Dependent Kinase Inhibitor 2A 2 3 5
  • P14ARF 2 3 4
  • CDK4I 2 3 4
  • MTS1 2 3 4
  • ARF 2 3 4
  • Cyclin-Dependent Kinase Inhibitor 2A (Melanoma, P16, Inhibits CDK4) 2 3
  • Cyclin-Dependent Kinase 4 Inhibitor A 3 4
  • Cyclin-Dependent Kinase Inhibitor 2A 3 4
  • Multiple Tumor Suppressor 1 3 4
  • Alternative Reading Frame 3 4
  • P16INK4A 3 4
  • CDKN2 3 4
  • MTS-1 3 4
  • CMM2 2 3
  • INK4 2 3
  • MLM 3 4
  • P14 2 3
  • P16 2 3
  • P19 2 3
  • Cell Cycle Negative Regulator Beta 3
  • CDK4 Inhibitor P16-INK4 3
  • Tumor Suppressor ARF 4
  • P16-INK4A 3
  • P16-INK4a 4
  • P16INK4a 2
  • P16-INK4 4
  • P16INK4 3
  • P19ARF 3
  • CDKN2A 5
  • P19Arf 2
  • INK4A 3
  • INK4a 2
  • TP16 3

External Ids for CDKN2A Gene

Previous HGNC Symbols for CDKN2A Gene

  • CDKN2
  • MLM

Previous GeneCards Identifiers for CDKN2A Gene

  • GC09M022295
  • GC09M022168
  • GC09M021957

Summaries for CDKN2A Gene

Entrez Gene Summary for CDKN2A Gene

  • This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

CIViC Summary for CDKN2A Gene

  • CDKN2A loss has been shown to be a significant event in a number of cancer types. While no targeted therapeutic has been engaged in clinical trials, the prognostic impact has been studied by a number of meta-analyses. In majority of cases CDKN2A is inactivated by homozygous deletions. One of the mechanisms by which loss of CDKN2A can occur is by hypermethylation of the promoter region for the gene. However, the prognostic impact of promoter hypermethylation has been relatively ambiguous. Many studies have suggesting poorer prognostic outcome for patients with hypermethylation in colorectal, liver, and younger lung cancer patients. This being said, there is still research to be done before this becomes a widely-accepted prognostic indicator. Additionally, CDKN2A (p16) expression is a surrogate marker for HPV infection. As such, CDKN2A expression is prognostic in Oropharyngeal and probably also non-oropharyngeal head and neck squamous cell carcinomas.

GeneCards Summary for CDKN2A Gene

CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) is a Protein Coding gene. Diseases associated with CDKN2A include Melanoma-Pancreatic Cancer Syndrome and Melanoma, Cutaneous Malignant 2. Among its related pathways are Apoptosis Modulation and Signaling and HIF1Alpha Pathway. Gene Ontology (GO) annotations related to this gene include transcription factor binding. An important paralog of this gene is CDKN2B.

UniProtKB/Swiss-Prot Summary for CDKN2A Gene

  • Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with COMMD1 and promotes its 'Lys63'-linked polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Isoform smARF may be involved in regulation of autophagy and caspase-independent cell death; the short-lived mitochondrial isoform is stabilized by C1QBP.
  • Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.

Gene Wiki entry for CDKN2A Gene

Additional gene information for CDKN2A Gene

No data available for Tocris Summary , PharmGKB "VIP" Summary , Rfam classification and piRNA Summary for CDKN2A Gene

Genomics for CDKN2A Gene

GeneHancer (GH) Regulatory Elements Pubs

Download GeneHancer 2017 data
Promoters and enhancers for CDKN2A Gene
- Elite GeneHancer and/or Elite GeneHancer-gene association Download GeneHancer data from 2017 publication | Request up-to-date GeneHancer data (full dataset)

GeneHancers around CDKN2A on the GeneHancer Hub at the UCSC Golden Path

Cistromic (ChIP-Seq) regulation report from SPP (The Signaling Pathways Project) for CDKN2A

Top Transcription factor binding sites by QIAGEN in the CDKN2A gene promoter:
  • AP-1
  • ATF-2

Genomic Locations for CDKN2A Gene

Genomic Locations for CDKN2A Gene
chr9:21,967,752-21,995,324
(GRCh38/hg38)
Size:
27,573 bases
Orientation:
Minus strand
chr9:21,967,751-21,995,300
(GRCh37/hg19)
Size:
27,550 bases
Orientation:
Minus strand

Genomic View for CDKN2A Gene

Genes around CDKN2A on UCSC Golden Path with GeneCards custom track

Cytogenetic band:
CDKN2A Gene in genomic location: bands according to Ensembl, locations according to GeneLoc (and/or Entrez Gene and/or Ensembl if different)
Genomic Location for CDKN2A Gene
GeneLoc Logo Genomic Neighborhood • Exon Structure • Gene Density

RefSeq DNA sequence for CDKN2A Gene

Proteins for CDKN2A Gene

Products:

  1. Antibody
  2. Protein
  3. Assay

  • Protein details for CDKN2A Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    Q8N726-ARF_HUMAN
    Recommended name:
    Tumor suppressor ARF
    Protein Accession:
    Q8N726
    Secondary Accessions:
    • D3DRK2
    • Q13195
    • Q13399
    • Q16360
    • Q7KZR9

    Protein attributes for CDKN2A Gene

    Size:
    132 amino acids
    Molecular mass:
    13903 Da
    Quaternary structure:
    • Does not interact with cyclins, CDK1, CDK2, CDK4, CDK5 or CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and UBE2I/UBC9. Interacts with TBRG1 and COMMD1. Interacts with CDKN2AIP and E4F1. Interacts with CDK5RAP3 and MDM2; form a ternary complex involved in regulation of p53/TP53 (PubMed:16173922). Isoform smARF interacts with C1QBP. Interacts with NOP53; the interaction is direct and promotes ARF nucleoplasmic relocalization and ubiquitin-mediated proteasomal degradation (PubMed:27323397).
    SequenceCaution:
    • Sequence=AAB01737.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=AAC60649.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=AAH15960.3; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=AAH21998.3; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=AAM77919.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=CAH70601.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=EAW58600.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; Sequence=EAW58601.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};

    Alternative splice isoforms for CDKN2A Gene

    UniProtKB/Swiss-Prot:

  • Protein details for CDKN2A Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P42771-CDN2A_HUMAN
    Recommended name:
    Cyclin-dependent kinase inhibitor 2A
    Protein Accession:
    P42771
    Secondary Accessions:
    • A5X2G7
    • D3DRK1
    • G3XAG3
    • O95440
    • Q15191
    • Q5VVJ5
    • Q96B52
    • Q9NP05

    Protein attributes for CDKN2A Gene

    Size:
    156 amino acids
    Molecular mass:
    16533 Da
    Quaternary structure:
    • Heterodimer with CDK4 or CDK6. Predominant p16 complexes contained CDK6. Interacts with CDK4 (both 'T-172'-phosphorylated and non-phosphorylated forms); the interaction inhibits cyclin D-CDK4 kinase activity. Interacts with ISCO2.
    SequenceCaution:
    • Sequence=AAB60645.1; Type=Erroneous initiation; Evidence={ECO:0000305};
    Miscellaneous:
    • [Isoform 5]: Barely detectable in non-tumor cells.

    Three dimensional structures from OCA and Proteopedia for CDKN2A Gene

    Alternative splice isoforms for CDKN2A Gene

    UniProtKB/Swiss-Prot:

neXtProt entry for CDKN2A Gene

Protein Expression for CDKN2A Gene

See protein expression from ProteomicsDB, MOPED, PaxDb, and MaxQB

Post-translational modifications for CDKN2A Gene

  • Ubiquitinated in normal cells by TRIP12 via the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination at the N-terminus, regardless of the absence of lysine residues. Ubiquitination leads to its proteasomal degradation. In cancer cells, however, TRIP12 is located in a different cell compartment, preventing ubiquitination and degradation.
  • Phosphorylation seems to increase interaction with CDK4.
  • Modification sites at PhosphoSitePlus
  • Modification sites at neXtProt

Other Protein References for CDKN2A Gene

ENSEMBL proteins:
REFSEQ proteins:

Antibody Products

No data available for DME Specific Peptides for CDKN2A Gene

Domains & Families for CDKN2A Gene

Gene Families for CDKN2A Gene

Human Protein Atlas (HPA):
  • Cancer-related genes
  • Disease related genes
  • Plasma proteins
  • Predicted intracellular proteins

Protein Domains for CDKN2A Gene

InterPro:
ProtoNet:

Suggested Antigen Peptide Sequences for CDKN2A Gene

GenScript: Design optimal peptide antigens:
  • Cyclin-dependent kinase inhibitor 2A (A7LNE7_HUMAN)
  • p16-INK4a (CD2A1_HUMAN)
  • p19ARF (CD2A2_HUMAN)
  • Truncated tumor suppressor protein P16 (D1LYX3_HUMAN)
  • P16 (Q208B5_HUMAN)

Graphical View of Domain Structure for InterPro Entry

P42771

UniProtKB/Swiss-Prot:

CDN2A_HUMAN :
  • Belongs to the CDKN2 cyclin-dependent kinase inhibitor family.
Family:
  • Belongs to the CDKN2 cyclin-dependent kinase inhibitor family.
genes like me logo Genes that share domains with CDKN2A: view

Function for CDKN2A Gene

Products:

  1. Animal Model
  2. CRISPR
  3. miRNA
  4. Inhibitory RNA
  5. Clone
  6. Cell Line

Molecular function for CDKN2A Gene

UniProtKB/Swiss-Prot Function:
Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with COMMD1 and promotes its 'Lys63'-linked polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Isoform smARF may be involved in regulation of autophagy and caspase-independent cell death; the short-lived mitochondrial isoform is stabilized by C1QBP.
UniProtKB/Swiss-Prot Function:
Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
GENATLAS Biochemistry:
cyclin dependent kinases 4 and 6 (CDK4/CDK6) inhibitor p16 (p16INK4A),blocking them from phosphorylating RB1 and preventing exit from G1 phase of the cell cycle, encoding for an alternative reading frame p14ARF,homolog to murine p19ARF,putatively inducing G1 and G2 phase arrest,inactivated (LOH) in preneoplastic pancreatic duct lesions in head and neck cancer in progression and inactivated by hypermethylation in childhood lymphoblastic leukemia (see TSG9A)

Phenotypes From GWAS Catalog for CDKN2A Gene

Gene Ontology (GO) - Molecular Function for CDKN2A Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0003677 DNA binding IEA --
GO:0003723 RNA binding HDA 22681889
GO:0004861 cyclin-dependent protein serine/threonine kinase inhibitor activity IDA 7739547
GO:0005515 protein binding IPI 9751050
GO:0008134 transcription factor binding IPI --
genes like me logo Genes that share ontologies with CDKN2A: view
genes like me logo Genes that share phenotypes with CDKN2A: view

Human Phenotype Ontology for CDKN2A Gene

HPO Id HPO Name Alternative Ids Definition Synonyms

Animal Models for CDKN2A Gene

MGI Knock Outs for CDKN2A:

Animal Model Products

CRISPR Products

Inhibitory RNA Products

  • Search GeneCopoeia for shRNA, lentivirus and/or AAV clone products for CDKN2A

Clone Products

No data available for Enzyme Numbers (IUBMB) , Transcription Factor Targets and HOMER Transcription for CDKN2A Gene

Localization for CDKN2A Gene

Subcellular locations from UniProtKB/Swiss-Prot for CDKN2A Gene

Nucleus, nucleolus. Nucleus, nucleoplasm.
[Isoform smARF]: Mitochondrion.
Cytoplasm. Nucleus.

Subcellular locations from

COMPARTMENTS
Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
COMPARTMENTS Subcellular localization image for CDKN2A gene
Compartment Confidence
nucleus 5
cytosol 5
mitochondrion 4
plasma membrane 3
extracellular 3
cytoskeleton 3
endoplasmic reticulum 3
endosome 3
golgi apparatus 3
peroxisome 2
lysosome 2

Subcellular locations from the

Human Protein Atlas (HPA)
  • Nucleoli (3)
See all subcellular structures

Gene Ontology (GO) - Cellular Components for CDKN2A Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0005634 nucleus IDA 16243918
GO:0005654 nucleoplasm TAS --
GO:0005730 nucleolus IEA --
GO:0005737 cytoplasm IDA 16243918
GO:0005739 mitochondrion IEA --
genes like me logo Genes that share ontologies with CDKN2A: view

Pathways & Interactions for CDKN2A Gene

genes like me logo Genes that share pathways with CDKN2A: view

Pathways by source for CDKN2A Gene

2 GeneGo (Thomson Reuters) pathways for CDKN2A Gene
  • Cell cycle Regulation of G1/S transition (part 1)
  • Transcription_P53 signaling pathway
10 Qiagen pathways for CDKN2A Gene
  • Cellular Apoptosis Pathway
  • CRHR Pathway
  • Cyclins and Cell Cycle Regulation
  • G1-S Phase Transition
  • Glioblastoma Multiforme
1 Cell Signaling Technology pathway for CDKN2A Gene
1 GeneTex pathway for CDKN2A Gene

SIGNOR curated interactions for CDKN2A Gene

Activates:
Inactivates:
Is activated by:
Is inactivated by:

Gene Ontology (GO) - Biological Process for CDKN2A Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000082 G1/S transition of mitotic cell cycle IDA 10208428
GO:0000209 protein polyubiquitination IDA --
GO:0001953 negative regulation of cell-matrix adhesion IMP 10205165
GO:0006364 rRNA processing IEA --
GO:0006469 negative regulation of protein kinase activity IMP --
genes like me logo Genes that share ontologies with CDKN2A: view

Drugs & Compounds for CDKN2A Gene

Products:

  1. Drug

(69) Drugs for CDKN2A Gene - From: DGIdb and Novoseek

Name Status Disease Links Group Role Mechanism of Action Clinical Trials
BAY1000394 Pharma Inhibition, Biomarker CDK4 Inhibitors, CDK2 Inhibitors 0
LEE011 Pharma inhibitor, Biomarker CDK4/6 inhibitor, CDK4 Inhibitors, Kinase Inhibitors 0
LY2835219 Pharma Inhibition, inhibitor, Biomarker CDK4/6 inhibitor,potent and selective, CDK4/6 inhibitor, CDK4 Inhibitors 0
PD 0332991 Pharma Biomarker CDK4 Inhibitors 0

(54) Additional Compounds for CDKN2A Gene - From: Novoseek

Name Synonyms Role CAS Number PubChem IDs PubMed IDs
genes like me logo Genes that share compounds with CDKN2A: view

Transcripts for CDKN2A Gene

Products:

  1. CRISPR
  2. miRNA
  3. Inhibitory RNA
  4. Clone

mRNA/cDNA for CDKN2A Gene

6 REFSEQ mRNAs :
19 NCBI additional mRNA sequence :
14 Ensembl transcripts including schematic representations, and UCSC links to gene/alias where relevant :

CRISPR Products

Inhibitory RNA Products

  • Search GeneCopoeia for shRNA, lentivirus and/or AAV clone products for CDKN2A

Clone Products

Alternative Splicing Database (ASD) splice patterns (SP) for CDKN2A Gene

ExUns: 1a · 1b · 1c ^ 2 ^ 3a · 3b ^ 4 ^ 5a · 5b · 5c ^ 6 ^ 7a · 7b · 7c ^ 8a · 8b · 8c · 8d
SP1: - - - - - - - - -
SP2: - - - -
SP3: - - -
SP4: - - - - - - - - - -
SP5: -
SP6: - - - - - - - - -
SP7: -
SP8: -

Relevant External Links for CDKN2A Gene

GeneLoc Exon Structure for
CDKN2A

Expression for CDKN2A Gene

Products:

  1. Primer
  2. Gene Expression Assay

mRNA expression in normal human tissues from GTEx, Illumina, BioGPS, and SAGE for CDKN2A Gene

mRNA expression in normal human tissues for CDKN2A Gene
mRNA expression by GTEx for CDKN2A GenemRNA expression by BioGPS for CDKN2A Gene

mRNA differential expression in normal tissues according to GTEx for CDKN2A Gene

This gene is overexpressed in Pituitary (x10.1).

Protein differential expression in normal tissues from HIPED for CDKN2A Gene

This gene is overexpressed in Plasma (32.3), Lung (14.1), and Bone marrow stromal cell (13.9).

Integrated Proteomics: protein expression in normal tissues and cell lines from ProteomicsDB, MaxQB, and MOPED for CDKN2A Gene



Transcriptomic regulation report from SPP (The Signaling Pathways Project) for CDKN2A

SOURCE GeneReport for Unigene cluster for CDKN2A Gene:

Hs.512599

mRNA Expression by UniProt/SwissProt for CDKN2A Gene:

Q8N726-ARF_HUMAN
Tissue specificity: Widely expressed but not detected in brain or skeletal muscle. Isoform 3 is pancreas-specific.

Evidence on tissue expression from TISSUES for CDKN2A Gene

  • Skin(4.7)
  • Nervous system(3.6)
  • Intestine(3.5)
  • Blood(3.3)
  • Pancreas(3.2)
  • Lymph node(3.1)
  • Bone marrow(3)
  • Liver(2.9)
  • Lung(2.9)
  • Kidney(2.9)
  • Bone(2.8)
  • Muscle(2.8)
  • Stomach(2.8)
  • Heart(2.7)
  • Spleen(2.7)
  • Thyroid gland(2.4)
  • Urine(2.3)
  • Eye(2.3)
  • Adrenal gland(2.3)
  • Saliva(2.1)
  • Gall bladder(2)

Phenotype-based relationships between genes and organs from Gene ORGANizer for CDKN2A Gene

Germ Layers:
  • ectoderm
  • endoderm
  • mesoderm
Systems:
  • digestive
  • endocrine
  • integumentary
  • lymphatic
  • nervous
  • respiratory
Regions:
Head and neck:
  • brain
  • cerebellum
  • eye
  • head
  • meninges
  • mouth
  • pharynx
Abdomen:
  • pancreas
General:
  • skin
genes like me logo Genes that share expression patterns with CDKN2A: view

No data available for Protein tissue co-expression partners for CDKN2A Gene

Orthologs for CDKN2A Gene

This gene was present in the common ancestor of chordates.

Orthologs for CDKN2A Gene

Organism Taxonomy Gene Similarity Type Details
Chimpanzee
(Pan troglodytes)
 Mammalia CDKN2A 30 31
  • 99.15 (n)
 OneToOne
Dog
(Canis familiaris)
 Mammalia CDKN2A 30
  • 86.67 (n)
Cow
(Bos Taurus)
 Mammalia CDKN2A 30 31
  • 85.04 (n)
 OneToOne
Rat
(Rattus norvegicus)
 Mammalia Cdkn2a 30
  • 76.96 (n)
Mouse
(Mus musculus)
 Mammalia Cdkn2a 30 17
  • 75.47 (n)
Platypus
(Ornithorhynchus anatinus)
 Mammalia -- 31
  • 66 (a)
 OneToMany
Oppossum
(Monodelphis domestica)
 Mammalia -- 31
  • 57 (a)
 ManyToMany
CDKN2A 31
  • 50 (a)
 ManyToMany
Chicken
(Gallus gallus)
 Aves CDKN2B 31
  • 57 (a)
 OneToMany
Lizard
(Anolis carolinensis)
 Reptilia -- 31
  • 56 (a)
 OneToMany
Tropical Clawed Frog
(Silurana tropicalis)
 Amphibia cdkn2b 30
  • 56.06 (n)
Zebrafish
(Danio rerio)
 Actinopterygii LOC100329528 30
  • 52.26 (n)
BX323448.2 31
  • 45 (a)
 ManyToMany
Species where no ortholog for CDKN2A was found in the sources mined by GeneCards:
  • A. gosspyii yeast (Eremothecium gossypii)
  • Actinobacteria (Mycobacterium tuberculosis)
  • African clawed frog (Xenopus laevis)
  • African malaria mosquito (Anopheles gambiae)
  • Alicante grape (Vitis vinifera)
  • Alpha proteobacteria (Wolbachia pipientis)
  • Amoeba (Dictyostelium discoideum)
  • Archea (Pyrococcus horikoshii)
  • Baker's yeast (Saccharomyces cerevisiae)
  • Barley (Hordeum vulgare)
  • Beta proteobacteria (Neisseria meningitidis)
  • Bread mold (Neurospora crassa)
  • Chromalveolata (Phytophthora infestans)
  • Common water flea (Daphnia pulex)
  • Corn (Zea mays)
  • E. coli (Escherichia coli)
  • Filamentous fungi (Aspergillus nidulans)
  • Firmicute Bacteria (Streptococcus pneumoniae)
  • Fission Yeast (Schizosaccharomyces pombe)
  • Fruit Fly (Drosophila melanogaster)
  • Green Algae (Chlamydomonas reinhardtii)
  • Honey Bee (Apis mellifera)
  • K. Lactis Yeast (Kluyveromyces lactis)
  • Loblloly Pine (Pinus taeda)
  • Malaria Parasite (Plasmodium falciparum)
  • Medicago Trunc (Medicago Truncatula)
  • Moss (Physcomitrella patens)
  • Orangutan (Pongo pygmaeus)
  • Pig (Sus scrofa)
  • Rainbow Trout (Oncorhynchus mykiss)
  • Rice (Oryza sativa)
  • Rice Blast Fungus (Magnaporthe grisea)
  • Schistosome Parasite (Schistosoma mansoni)
  • Sea Anemone (Nematostella vectensis)
  • Sea Vase (Ciona intestinalis)
  • Sea Squirt (Ciona savignyi)
  • Sea Urchin (Strongylocentrotus purpuratus)
  • Sorghum (Sorghum bicolor)
  • Soybean (Glycine max)
  • Stem Rust Fungus (Puccinia graminis)
  • Sugarcane (Saccharum officinarum)
  • Thale Cress (Arabidopsis thaliana)
  • Tomato (Lycopersicon esculentum)
  • Toxoplasmosis (Toxoplasma gondii)
  • Trichoplax (Trichoplax adhaerens)
  • Wheat (Triticum aestivum)
  • Worm (Caenorhabditis elegans)

Evolution for CDKN2A Gene

ENSEMBL:
Gene Tree for CDKN2A (if available)
TreeFam:
Gene Tree for CDKN2A (if available)
Aminode:
Evolutionary constrained regions (ECRs) for CDKN2A: view image

Paralogs for CDKN2A Gene

Paralogs for CDKN2A Gene

(18) SIMAP similar genes for CDKN2A Gene using alignment to 14 proteins:

  • CD2A1_HUMAN
  • CD2A2_HUMAN
  • A7LNE7_HUMAN
  • D1LYX3_HUMAN
  • G3XAG3_HUMAN
  • J3QRG6_HUMAN
  • K7ENC6_HUMAN
  • K7ES20_HUMAN
  • K7PML8_HUMAN
  • L8E941_HUMAN
  • Q208B5_HUMAN
  • Q2MJK0_HUMAN
  • Q5ZEY9_HUMAN
  • Q9UPB7_HUMAN
genes like me logo Genes that share paralogs with CDKN2A: view

Variants for CDKN2A Gene

Products:

  1. SNP Genotyping and Copy Number Assay

Sequence variations, with clinical significance, from ClinVar and Humsavar, with links to dbSNP for CDKN2A Gene

SNP ID Clinical significance and condition Chr 09 pos Variation AA Info Type
30044 Risk Factor: Cutaneous malignant melanoma 2 21,994,171(-) C/T MISSENSE_VARIANT,INTRON_VARIANT
635365 Not Provided: not provided 21,971,209(-) C/T SPLICE_ACCEPTOR_VARIANT
635366 Not Provided: not provided 21,970,900(-) A/G SPLICE_DONOR_VARIANT
635367 Not Provided: not provided 21,970,901(-) C/A SPLICE_DONOR_VARIANT
635368 Not Provided: not provided 21,970,901(-) C/T SPLICE_DONOR_VARIANT

Additional dbSNP identifiers (rs#s) for CDKN2A Gene

Structural Variations from Database of Genomic Variants (DGV) for CDKN2A Gene

Variant ID Type Subtype PubMed ID
esv1425040 CNV deletion 17803354
esv2764150 CNV gain+loss 21179565
nsv1018514 CNV gain 25217958
nsv8426 CNV loss 18304495

Variation tolerance for CDKN2A Gene

Residual Variation Intolerance Score: 89.6% of all genes are more intolerant (likely to be disease-causing)
Gene Damage Index Score: 0.70; 14.90% of all genes are more intolerant (likely to be disease-causing)

Additional Variant Information for CDKN2A Gene

Human Gene Mutation Database (HGMD)
CDKN2A
SNPedia medical, phenotypic, and genealogical associations of SNPs for
CDKN2A

No data available for Polymorphic Variants from UniProtKB/Swiss-Prot for CDKN2A Gene

Disorders for CDKN2A Gene

MalaCards: The human disease database

(311) MalaCards diseases for CDKN2A Gene - From: UniProtKB/Swiss-Prot, LncRNADisease, OMIM, ClinVar, GTR, Orphanet, DISEASES, Novoseek, and GeneCards

Disorder Aliases PubMed IDs
melanoma-pancreatic cancer syndrome
  • familial atypical multiple mole melanoma-pancreatic carcinoma syndrome; fammmpc
melanoma, cutaneous malignant 2
  • melanoma, cutaneous malignant, susceptibility to, 2
melanoma-astrocytoma syndrome
  • melanoma and neural system tumor syndrome
dysplastic nevus syndrome
  • b-k mole syndrome
hereditary melanoma
  • familial melanoma
- elite association - COSMIC cancer census association via MalaCards

UniProtKB/Swiss-Prot

CDN2A_HUMAN
  • Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.
  • Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269 PubMed:10651484, ECO:0000269 PubMed:10874641, ECO:0000269 PubMed:11506491, ECO:0000269 PubMed:12019208, ECO:0000269 PubMed:14646619, ECO:0000269 PubMed:19260062, ECO:0000269 PubMed:7987387, ECO:0000269 PubMed:8595405, ECO:0000269 PubMed:8653684, ECO:0000269 PubMed:8710906, ECO:0000269 PubMed:9328469, ECO:0000269 PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
  • Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269 PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.

Additional Disease Information for CDKN2A

Genetic Association Database
(GAD)
Human Genome Epidemiology Navigator
(HuGE)
ATLAS of Genetics and Cytogenetics in Oncology and Haematology
Open Targets Platform
genes like me logo Genes that share disorders with CDKN2A: view

No data available for Genatlas for CDKN2A Gene

Publications for CDKN2A Gene

  1. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. (PMID: 19260062) Kannengiesser C … Bressac-de Paillerets B (Human mutation 2009) 3 4 23
  2. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. (PMID: 19101490) Ohta S … Kubota Y (Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2009) 3 23 41
  3. MTAP and CDKN2B genes are associated with myocardial infarction in Chinese Hans. (PMID: 19272367) Yang XC … Wang XF (Clinical biochemistry 2009) 3 23 41
  4. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value. (PMID: 19594747) Jardin F … Tilly H (British journal of haematology 2009) 3 23 41
  5. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. (PMID: 19224585) Polakova V … Vodicka P (Human mutation 2009) 3 23 41

ExternalLinks

View latest publications for CDKN2A gene in Mastermind

Products for CDKN2A Gene